T. Lushnikova et al., DNA copy number changes in epithelioid sarcoma and its variants: A comparative genomic hybridization study, MOD PATHOL, 13(10), 2000, pp. 1092-1096
Citations number
29
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Epithelioid sarcoma is a distinctive, rare soft tissue sarcoma that typical
ly involves the distal extremities in young adults, and shows epithelioid m
orphology and immunohistochemical markers of epithelial differentiation. Th
e genetic background of epithelioid sarcoma is poorly understood, and knowl
edge of it could give insights into the pathogenesis of this tumor and its
possible relationship with other malignant tumors. In this study, we analyz
ed DNA copy number changes in 30 epithelioid sarcomas by comparative genomi
c hybridization, DNA was extracted from microdissected samples of formaldeh
yde-fixed and paraffin-embedded tumors with a minimum of 60% of tumor cells
in each sample. Sixteen tumors (53%) showed DNA copy number changes at one
to six different genomic sites. The majority of the changes were gains, se
en in 14 tumors, whereas 10 tumors showed losses. The most common recurrent
gains were at 11q13 (five cases), 1q21-q23 (four cases), 6p21.3 (three cas
es), and 9q31-qter (three cases). High-level amplifications were detected o
nce in 6p21.3-p21.1 and once in 9q32-qter, Recurrent losses were seen at 9p
ter-p23 (three cases), 13q22-q32 (three cases), 1p13-p22 (two cases), 3p12-
p14 (two cases), 4q13-q33 (two cases), 9p21 (two cases), and 13q32-qter (tw
o cases). The most common recurrent gain at 11q13 was seen in both classic
cases and angiomatoid and rhabdoid variants supporting the relationship of
these variants with the classic epithelioid sarcoma, Expression of cyclin D
1 gene, located in 11q13, was immunohistochemically detected in nine of 15
cases including three of five cases with gain of 11q13, suggesting its invo
lvement in epithelioid sarcoma The observed comparative genomic hybridizati
on changes give targets for future genetic studies on epithelioid sarcoma.